Category: Press Release
CGTN: “شركاء في التميز”: الصين والبرازيل تسعيان إلى إقامة عالم أكثر عدالة وكوكب أكثر استدامة
بكين, Nov. 23, 2024 (GLOBE NEWSWIRE) — نشرت شبكة تلفزيون الصين الدولية CGTN مقالًا عن مساعي الصين والبرازيل لإقامة عالم أكثر عدالة وكوكب أكثر استدامة. في عام 2014، وُقّعت اتفاقية
Issa Odeh, 18, and Antony Saleh, 17, from Palestine win NFTE’s World Youth Entrepreneurship Challenge
The Water World founders competed against students from 10 countries to secure a $5,000 grand prize New York, NY, Nov. 22, 2024 (GLOBE NEWSWIRE) — Global nonprofit Network for Teaching
ELAN IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important December 6 Deadline in Securities Class Action – ELAN
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November
LLAP DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important November 26 Deadline in Securities Class Action – LLAP
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) —WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Terran Orbital Corporation (NYSE: LLAP) between August 15, 2023
POWW IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AMMO, Inc. Investors to Secure Counsel Before Important November 29 Deadline in Securities Class Action – POWW
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020
MGX DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to